Development of anti-inflammatory treatment with low dose colchicine for prevention of host inflammatory response phase in patients with novel coronavirus disease (COVID-19) through a physician-initiated clinical trial
- Funded by Japan Agency for Medical Research and Development (AMED)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Funder
Japan Agency for Medical Research and Development (AMED)Principal Investigator
PendingResearch Location
JapanLead Research Institution
Department of Respiratory diseases and infection, University of the RyukyusResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Clinical trial (unspecified trial phase)
Special Interest Tags
N/A
Study Subject
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified